GlassScriptPhysician profile
Donald E Stillwagon
NPI 1396777587
$1,705.86
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,143 · 2020: $324 · 2023: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $280.68 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $201.68 | 2019-2020 | |
| Novo Nordisk INC | $168.50 | 2019-2020 | |
| Glaxosmithkline, LLC. | $146.55 | 2019 | |
| Pfizer INC. | $143.12 | 2019-2020 | |
| Abbvie INC. | $141.21 | 2020-2023 | Ubrelvy, Qulipta |
| Inspire Medical Systems, INC. | $124.74 | 2023 | Inspire |
| Lilly USA, LLC | $112.55 | 2019-2020 | |
| Shire North American Group INC | $83.55 | 2019 | |
| Abbott Laboratories | $72.19 | 2019 | |
| Merck Sharp & Dohme LLC | $46.88 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.64 | 2019-2020 | |
| Genentech USA, INC. | $32.86 | 2019 | |
| Vertiflex, INC. | $30.30 | 2019 | |
| Allergan, INC. | $30.15 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $17.46 | 2020 | |
| Antares Pharma, INC. | $15.45 | 2019 | |
| Neuronetics, INC. | $13.21 | 2020 | |
| Adlon Therapeutics L.P. | $11.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Stillwagon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.